Allegan

Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications

Perrigo Co. announced it has kicked off a broad industry marketing and communications campaign to raise awareness for, and consumer confidence in, generic over-the-counter medications sold at leading retailers — also known as “store brand” OTCs.

WWJ Newsradio 950–2013/05/13

Perrigo Reports Record Revenue; Acquisition Charges Ding Profits

The generic drug and store brand health products maker Perrigo Co. (Nasdaq: PRGO) Wednesday reported record revenue of $919.8 million in the third fiscal quarer ended March 30, up from $778 million a year earlier.

WWJ Newsradio 950–2013/05/08

Perrigo Closes Acquisition Of Pet Health Company Velcera

Perrigo Co. (Nasdaq: PRGO) Monday announced that it has closed the acquisition of Velcera Inc., the Yardley, Pa.-based pet health products company, for $160 million in cash.

WWJ Newsradio 950–2013/04/01

Perrigo Starting Shipments of Guaifenesin Extended-Release 600mg

Perrigo Co. (Nasdaq: PRGO) Monday announced that it has begun shipments of Guaifenesin 600mg Extended-Release tablets in a launch to its retail and wholesale customers

WWJ Newsradio 950–2013/03/18

Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%

Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for testosterone gel 1.62 percent and that it has notified AbbVie Inc., the owner of the Reference Listed Drug of its filing.

WWJ Newsradio 950–2013/02/19

Perrigo Confirms FDA Approval For Testosterone Gel 1%

Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo’s NDA included a bioequivalence study that compared its product to AbbVie’s AndroGel 1%.

WWJ Newsradio 950–2013/02/06

Perrigo Reports Record Second Quarter Revenue, Higher Profit

The Allegan generic drugmaker Perrigo Co. Friday record revenue of $883 million for its second fiscal quarter ended Dec. 29, up from $838.2 million in the same quarter a year earlier. Net income for the quarter was $106 million or $1.12 a share, up from $99.7 million or $1.06 aa share in the same quarter a year earlier.

WWJ Newsradio 950–2013/02/03